Strides Pharma Science Limited

Web: strides.com NSE: STAR BSE: 532531 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

1033 8(-1%)

Volume

2L as on 23, Jun

Open

701

High

701

Low

685

1,041

VWAP

1,122

52 Week High

1,231

52 Week Low

769

Viand Research Rating

Quality Score

62/100

Growth Score

58/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

9,521

No. of Shares

9.22

P/E

194.46

P/B

4.17

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

2.14

ROCE

Profit Growth

Listing Date

02-Feb-00

Promoter Holding

27.91%

FII Holding

28.68%

DII Holding

14.44%

Price Chart

Price Performance

1 Week1%

1 Month4%

3 Months22%

6 Months27%

1 Year27%

YTD27%

Moving Average

5 Day SMA1,111

10 Day SMA1,077

20 Day SMA1,077

30 Day SMA1,103

50 Day SMA1,082

61 Day SMA1,059

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,142	1,121	1,132	1,149
Resistance 2	1,132	1,120	1,125	1,136
Resistance 1	1,124	1,118	1,121	1,131
Pivot Point	1,114	1,116	1,114	1,118
Support 1	1,106	1,115	1,107	1,113
Support 2	1,096	1,113	1,103	1,100
Support 3	1,088	1,111	1,096	1,095

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.11) 27.91%	(0.01) 27.86%	(-0.41) 27.86%	(0.01) 28.30%	(1.51) 28.30%	(1.01) 26.82%	(0.01) 25.84%	(0.01) 25.86%	(-1.51) 25.88%	(-0.41) 27.39%	(-0.31) 27.79%	(-0.21) 28.08%	(-2.61) 28.28%	(-0.21) 30.90%	(0.71) 31.08%	(-0.21) 30.37%	(1.01) 30.60%	(0.01) 29.60%	(0.01) 29.60%
FIIs	(-0.81) 28.68%	(1.01) 29.52%	(0.51) 28.51%	(-0.31) 28.02%	(-0.21) 28.32%	(-1.61) 28.48%	(3.41) 30.08%	(2.11) 26.71%	(5.11) 24.57%	(2.21) 19.45%	(0.51) 17.25%	(-2.11) 16.72%	(-0.11) 18.85%	(-2.51) 18.98%	(0.21) 21.43%	(1.61) 21.21%	(-0.21) 19.66%	(-5.11) 19.85%	(0.01) 24.96%
DIIs	(1.41) 14.44%	(0.01) 13.02%	(-0.31) 12.98%	(-0.41) 13.30%	(-3.21) 13.72%	(-1.31) 16.92%	(0.11) 18.24%	(0.51) 18.17%	(-1.41) 17.66%	(-0.51) 19.02%	(-0.11) 19.50%	(1.71) 19.60%	(-0.61) 17.88%	(3.41) 18.44%	(-1.61) 15.07%	(-2.21) 16.63%	(-2.31) 18.82%	(0.61) 21.08%	(0.01) 20.44%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.39%	0.39%	0.39%	0.40%	0.40%	0.40%	0.40%	0.40%	0.00%	0.00%	0.00%	0.00%
Public	28.96%	29.59%	30.62%	30.38%	29.65%	27.78%	25.83%	28.87%	31.52%	33.75%	35.06%	35.22%	34.60%	31.29%	32.05%	31.79%	30.92%	29.47%	25.00%
No. of Shareholders	86,616	85,589	91,206	92,889	95,125	114,236	96,009	91,917	84,695	91,182	101,638	112,775	120,916	123,964	130,682	134,718	133,190	125,553	106,927

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	1323	1195	1221	1120	1190	1154	1167	1054	1044	1006	999	930	986	865	897	940	866	794	721	688
Sales Growth % (YoY)	11.2%	3.6%	4.6%	6.2%	14.1%	14.7%	16.8%	13.4%	5.8%	16.3%	11.4%	-1.1%	13.9%	8.9%	24.3%	36.6%	-4.7%	-4.5%	-9.1%	-12%
Sales Growth % (QoQ)	10.7%	-2.1%	9%	-5.9%	3.1%	-1.1%	10.7%	1%	3.8%	0.7%	7.4%	-5.7%	14%	-3.6%	-4.6%	8.5%	9.1%	10.1%	4.8%	-
Expenses	1084	959	990	902	973	943	983	866	874	876	889	796	871	892	844	936	868	817	759	758
Operating Profit	240	236	231	218	218	210	184	188	169	129	111	134	115	-27	53	4	-1	-23	-37	-70
OPM %	18	20	19	19	18	18	16	18	16	13	11	14	12	-3	6	0	0	-3	-5	-10
Other Income	3	104	18	0	-12	4	25	3299	-27	60	-129	3	20	68	57	-52	9	-5	-38	-78
Interest	42	43	46	47	50	52	74	73	71	70	79	76	81	58	68	55	49	42	44	41
Depreciation	53	51	50	49	49	48	48	47	48	49	60	60	61	60	62	60	61	61	57	55
Profit before tax	148	245	153	122	106	114	86	3369	23	70	-157	0	-7	-78	-20	-163	-103	-131	-175	-244
Tax %	13	15	14	13	20	21	16	1	55	23	-5	3025	106	5	-197	-17	-128	-3	-4	-15
Net Profit	129	208	132	106	86	90	72	3350	10	54	-149	-9	-14	-82	19	-135	29	-127	-168	-209
Net Profit Growth % (QoQ)	-38%	57.6%	24.5%	23.3%	-4.4%	25%	-97.9%	33400%	-81.5%	136.2%	-1555.6%	35.7%	82.9%	-531.6%	114.1%	-565.5%	122.8%	24.4%	19.6%	-
Net Profit Growth % (YoY)	50%	131.1%	83.3%	-96.8%	760%	66.7%	148.3%	37322.2%	171.4%	165.9%	-884.2%	93.3%	-148.3%	35.4%	111.3%	35.4%	-	-	-	-
TTM Net Profit	575	532	414	354	3598	3522	3486	3265	-94	-118	-254	-86	-212	-169	-214	-401	-475	-504	-377	0
EPS in Rs	13.77	21.93	13.84	10.8	8.91	9.54	7.81	364.69	1.98	5.4	-14.54	-0.79	-1.06	-8.86	2.53	-15.13	3.25	-13.55	-18.1	-22.87

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Dec 2012	Jan 1900
Sales	4859	4565	3890	3688	3070	3316	2752	2178	2845	2755	2861	1196	1341	962	1341
Sales Growth %	6.4%	17.4%	5.5%	20.1%	-7.4%	20.5%	26.3%	-23.4%	3.2%	-3.7%	139.2%	-10.8%	39.4%	-62.3%	-
Expenses	3933	3763	3362	3544	3201	2779	2338	1982	2448	2228	2486	967	1567	861	1567
Operating Profit	925	803	528	145	-131	537	414	197	398	527	374	229	-226	101	-226
OPM %	19	18	14	4	-4	16	15	9	14	19	13	19	-17	10	-17
Other Income	124	3313	-100	92	-112	109	-43	303	643	291	63	874	3281	959	3281
Interest	179	249	280	261	177	150	156	79	196	183	168	47	109	79	109
Depreciation	202	192	214	243	233	206	174	117	154	126	131	64	56	31	56
Profit before tax	669	3675	-65	-268	-653	289	42	303	690	509	137	992	2890	949	2890
Tax %	14	2	45	-21	-27	11	27	-9	1	12	31	15	39	11	39
Net Profit	575	3598	-94	-212	-474	258	31	330	684	446	95	844	1767	847	1767
Net Profit Growth %	-84%	3927.7%	55.7%	55.3%	-283.7%	732.3%	-90.6%	-51.8%	53.4%	369.5%	-88.7%	-52.2%	108.6%	-52.1%	-
EPS in Rs	60.34	389.75	-7.68	-22.44	-51.25	29.93	4.06	36.27	74.25	44.71	12.15	141.78	296.43	143.92	296.43
Dividend Payout %	8	1	-33	-7	0	8	345	8	3	10	41	76	170	1	170

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Dec 2012
Cash from Operating Activity	703	684	701	44	-258	481	205	60	187	288	73	83	-272	139
Cash from Investing Activity	-173	-90	-150	302	-119	-522	1321	-145	570	-1222	-2205	50	4044	771
Cash from Financing Activity	-453	-643	-693	-214	421	-16	-1709	194	-1016	338	2944	-421	-3319	-990
Net Cash Flow	76	-48	-142	133	45	-56	-184	110	-259	-596	812	-288	454	-80

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Dec 2012
Equity Capital	92	92	92	92	92	90	90	90	90	90	90	89	89	60	60	59
Reserves	3015	2664	2460	2179	2034	2122	2269	2687	2438	2559	2374	2659	2569	1085	947	1967
Borrowings	1758	1844	1880	2308	2517	3030	3025	2348	2235	3221	2520	3700	3542	892	547	1594
Other Liabilities	2062	1921	1498	1410	1157	1352	1556	1844	1369	1937	1601	1598	1211	438	543	1175
Total Liabilities	6927	6521	5929	5990	5799	6594	6940	6969	6131	7807	6585	8046	7410	2475	2096	4796
Fixed Assets	2387	2139	1899	1987	1865	2311	2347	2219	2099	3648	2977	2980	2679	701	555	3017
CWIP	161	164	207	154	162	151	291	447	413	453	620	780	815	171	99	241
Investments	291	440	409	243	303	490	540	697	549	702	588	1525	1341	630	443	0
Other Assets	4088	3777	3414	3605	3470	3642	3762	3605	3070	3005	2400	2762	2576	972	999	1538
Total Assets	6927	6521	5929	5990	5799	6594	6940	6969	6131	7807	6585	8046	7410	2475	2096	4796

Delivery

#	Date	966 25% 1211	Value (Cr)	Q/T 15	Del 40	Del 28
1	22-Jul	1041	29	12	47	14
2	21-Jul	1051	9	10	45	4
3	20-Jul	1060	14	11	51	7
4	17-Jul	1075	44	14	49	22
5	16-Jul	1049	16	12	61	10
6	15-Jul	1060	7	10	39	3
7	14-Jul	1071	7	10	38	3
8	13-Jul	1074	11	9	41	4
9	10-Jul	1083	33	14	49	16
10	9-Jul	1076	24	13	49	12
11	8-Jul	1081	12	10	49	6
12	7-Jul	1128	9	8	57	5
13	6-Jul	1122	7	10	42	3
14	3-Jul	1127	11	11	46	5
15	2-Jul	1126	21	12	44	9
16	1-Jul	1094	11	11	40	4
17	30-Jun	1093	22	16	55	12
18	29-Jun	1103	27	12	37	10
19	25-Jun	1082	20	16	64	13
20	24-Jun	1111	8	9	41	3
21	23-Jun	1111	18	12	29	5
22	22-Jun	1116	10	9	51	5
23	19-Jun	1111	8	9	42	3
24	18-Jun	1111	14	10	36	5
25	17-Jun	1107	13	9	36	5
26	16-Jun	1103	19	11	45	9
27	15-Jun	1085	46	11	43	20
28	12-Jun	1056	56	22	55	31
29	11-Jun	989	20	12	39	8
30	10-Jun	978	27	20	48	13
31	9-Jun	1017	15	15	41	6
32	8-Jun	1006	26	13	45	11
33	5-Jun	1045	38	18	44	17
34	4-Jun	1027	34	16	56	19
35	3-Jun	1081	14	12	42	6
36	2-Jun	1075	23	12	49	11
37	1-Jun	1094	21	17	51	11
38	29-May	1112	59	14	52	31
39	27-May	1154	21	15	45	9
40	26-May	1169	33	14	45	15
41	25-May	1188	31	19	42	13
42	22-May	1153	17	15	50	9
43	21-May	1159	25	17	36	9
44	20-May	1142	75	17	28	21
45	19-May	1154	146	14	37	54
46	18-May	1151	176	15	16	28
47	15-May	1154	15	12	30	4
48	14-May	1155	14	11	30	4

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	9,521c	89c	0.93
22-Jul	9,611c	93c	0.96
21-Jul	9,704c	366c	3.63
17-Jul	10,070c	425c	4.41
16-Jul	9,645c	169c	1.72
15-Jul	9,814c	58c	0.59
14-Jul	9,872c	136c	1.36
13-Jul	10,008c	20c	0.20
10-Jul	9,988c	107c	1.08
09-Jul	9,881c	147c	1.46
08-Jul	10,028c	368c	3.54
07-Jul	10,395c	45c	0.44
06-Jul	10,350c	148c	1.45
02-Jul	10,203c	64c	0.63
01-Jul	10,139c	138c	1.38
30-Jun	10,001c	270c	2.63
29-Jun	10,271c	361c	3.65
26-Jun	9,910c	228c	2.25
25-Jun	10,137c	91c	0.89
24-Jun	10,228c	3c	0.03
23-Jun	10,231c	46c	0.45
22-Jun	10,277c	32c	0.31
19-Jun	10,310c	124c	1.22
17-Jun	10,185c	9c	0.09
16-Jun	10,176c	212c	2.13
15-Jun	9,964c	194c	1.98
12-Jun	9,770c	553c	6.00
11-Jun	9,217c	127c	1.40
10-Jun	9,090c	0	0

Stock Checklist

Price is above from 52 week high low average: 14%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: YES

Mutual Fund Holdings

Held by 32 fund scheme(s) across 10 fund house(s) as of Jul26 · Total value ₹1,624 Cr · 4 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
quant Mutual Fund	6	7.15%	-	1043.8
Bandhan Mutual Fund	6	0.37%	-	304.5
Axis Mutual Fund	2	0.29%	-	137.9
Aditya Birla Sun Life Mutual Fund	2	0.59%	-	76
Motilal Oswal Mutual Fund	4	0.45%	-	40.2
WhiteOak Capital Mutual Fund	2	1.42%	+0.15%	18.8
Samco Mutual Fund	4	0.26%	+0.03%	2.5
Groww Mutual Fund	2	0.03%	-	0.2
Angel One Mutual Fund	2	0.03%	-	0
Mirae Asset Mutual Fund	2	0.03%	-	0

Strides Pharma Science Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements